logo

OPT(Delisted)

OptheaยทNASDAQ
--
--(--)

OPT Profile

Opthea Limited

A clinical stage biopharmaceutical company that develops novel therapies to treat highly prevalent and progressive retinal diseases

--
--
10/16/2020
NASDAQ Stock Exchange
10
06-30
Depository Receipts (Ordinary Shares)
Level 9 , 505 Little Collins Street, Melbourne, VIC 3000, Australia
Drug development
Opthea Limited was incorporated under the laws of Australia in 1984 as Circadian Technologies Limited. The company is a clinical-stage biopharmaceutical company developing a novel therapy for the treatment of highly prevalent and progressive retinal diseases.